Long‐Term Outcomes in Patients With Hemorrhagic Moyamoya Disease Combined With Hypertension After Encephaloduroarteriosynangiosis
This study highlights significant differences in hematoma recurrence-free survival and OS between patients with hemorrhagic MMD with and without hypertension. A subgroup analysis of those with hypertension showed that optimal blood pressure control notably lowered hematoma recurrence but did not improve OS. For patients with hemorrhagic MMD with hypertension, optimizing blood pressure alone may be insufficient, emphasizing the importance of personalized integrated strategies for this patient subgroup.
Authors
- Manli Xie
- Qian‐Nan Wang (ORCID: https://orcid.org/0000-0002-6389-2347)
- Qingbao Guo (ORCID: https://orcid.org/0000-0001-6538-375X)
- Huanhuan Ji (ORCID: https://orcid.org/0000-0002-0187-0038)
- Lian Duan (ORCID: https://orcid.org/0000-0001-7210-056X)
- Xiangyang Bao (ORCID: https://orcid.org/0000-0003-1204-7386)
Institutions
- Chinese PLA General Hospital (CN)
- Xian Central Hospital (CN)
- Wuhan No.1 Hospital (CN)
- Wuhan No.9 Hospital (CN)
- First Hospital of Xi'an (CN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1161/jaha.124.039054
- Citations
- 1
- Primary Topic
- Moyamoya disease diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.67